This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Apr 20;29(12):1506-8.

doi: 10.1200/JCO.2010.34.0745. Epub 2011 Mar 21.

Immune readouts may have prognostic value for the course of merkel cell carcinoma, a virally associated disease

Christopher B Buck, Douglas R Lowy

PMID: 21422431
PMCID: PMC6294996
DOI: 10.1200/JCO.2010.34.0745

Editorial

Immune readouts may have prognostic value for the course of merkel cell carcinoma, a virally associated disease

Christopher B Buck et al. J Clin Oncol. 2011.

. 2011 Apr 20;29(12):1506-8.

doi: 10.1200/JCO.2010.34.0745. Epub 2011 Mar 21.

Authors

Christopher B Buck, Douglas R Lowy

PMID: 21422431
PMCID: PMC6294996
DOI: 10.1200/JCO.2010.34.0745

No abstract available

PubMed Disclaimer

Comment on

Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR, Koelle DM, Galloway DA, Leonard JH, Madeleine MM, Argenyi ZB, Disis ML, Becker JC, Cleary MA, Nghiem P. Paulson KG, et al. J Clin Oncol. 2011 Apr 20;29(12):1539-46. doi: 10.1200/JCO.2010.30.6308. Epub 2011 Mar 21. J Clin Oncol. 2011. PMID: 21422430 Free PMC article.
High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.
Touzé A, Le Bidre E, Laude H, Fleury MJ, Cazal R, Arnold F, Carlotti A, Maubec E, Aubin F, Avril MF, Rozenberg F, Tognon M, Maruani A, Guyetant S, Lorette G, Coursaget P. Touzé A, et al. J Clin Oncol. 2011 Apr 20;29(12):1612-9. doi: 10.1200/JCO.2010.31.1704. Epub 2011 Mar 21. J Clin Oncol. 2011. PMID: 21422439

Similar articles

High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.
Touzé A, Le Bidre E, Laude H, Fleury MJ, Cazal R, Arnold F, Carlotti A, Maubec E, Aubin F, Avril MF, Rozenberg F, Tognon M, Maruani A, Guyetant S, Lorette G, Coursaget P. Touzé A, et al. J Clin Oncol. 2011 Apr 20;29(12):1612-9. doi: 10.1200/JCO.2010.31.1704. Epub 2011 Mar 21. J Clin Oncol. 2011. PMID: 21422439
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR, Koelle DM, Galloway DA, Leonard JH, Madeleine MM, Argenyi ZB, Disis ML, Becker JC, Cleary MA, Nghiem P. Paulson KG, et al. J Clin Oncol. 2011 Apr 20;29(12):1539-46. doi: 10.1200/JCO.2010.30.6308. Epub 2011 Mar 21. J Clin Oncol. 2011. PMID: 21422430 Free PMC article.
Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
Ricci C, Righi A, Ambrosi F, Gibertoni D, Maletta F, Uccella S, Sessa F, Asioli S, Pellilli M, Maragliano R, La Rosa S, Papotti MG, Asioli S. Ricci C, et al. Endocr Pathol. 2020 Mar;31(1):21-32. doi: 10.1007/s12022-019-09601-5. Endocr Pathol. 2020. PMID: 31808008
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma).
Smith DF, Messina JL, Perrott R, Berman CG, Reintgen DS, Cruse CW, Glass FL, Fenske NA, DeConti RC, Trotti A 3rd. Smith DF, et al. Cancer Control. 2000 Jan-Feb;7(1):72-83. Cancer Control. 2000. PMID: 10740663 Review. No abstract available.
Updates on Merkel Cell Carcinoma.
Emge DA, Cardones AR. Emge DA, et al. Dermatol Clin. 2019 Oct;37(4):489-503. doi: 10.1016/j.det.2019.06.002. Dermatol Clin. 2019. PMID: 31466589 Review.

See all similar articles

Cited by

MoS₂-based nanocomposites for cancer diagnosis and therapy.
Wang J, Sui L, Huang J, Miao L, Nie Y, Wang K, Yang Z, Huang Q, Gong X, Nan Y, Ai K. Wang J, et al. Bioact Mater. 2021 Apr 27;6(11):4209-4242. doi: 10.1016/j.bioactmat.2021.04.021. eCollection 2021 Nov. Bioact Mater. 2021. PMID: 33997503 Free PMC article. Review.

References

1. Lemos BD, Storer BE, Iyer JG, et al.: Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 63:751–61, 2010 - PMC - PubMed
1. Rockville Merkel Cell Carcinoma Group: Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol 27:4021–6, 2009 - PMC - PubMed
1. Feng H, Shuda M, Chang Y, et al.: Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–100, 2008 - PMC - PubMed
1. Touze A, Le Bidre E, Laude H, et al.: High levels of antibodies against Merkel cell polyomavirus identify a subset of Merkel cell carcinoma patients with better clinical outcome. J Clin Oncol in press, 2011 - PubMed
1. Paulson KG, Iyer JG, Tegeder AR, et al.: Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol In press, 2011 - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information